Drugs / Dehypotin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01108978 Comparator | May 2010 → May 2011 | cardiovascular disorder, hyperlipoproteinemia, type 2 diabetes mellitus | Nang Kuang Pharmaceutical Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dehypotin | “Dehypotin® 40 mg/day or placebo, once a day, shortly after baseline for 12 consecutive weeks” NCT01108978 ↗ |